Fifth Third Wealth Advisors LLC Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fifth Third Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 44.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,199 shares of the medical equipment provider’s stock after purchasing an additional 371 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $479,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Baystate Wealth Management LLC increased its position in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC grew its position in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares during the period. Able Wealth Management LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $28,000. Atticus Wealth Management LLC grew its position in Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 41 shares during the period. Finally, MeadowBrook Investment Advisors LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, SVP Mark Brosius sold 175 shares of Intuitive Surgical stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $389.16, for a total transaction of $68,103.00. Following the sale, the senior vice president now owns 883 shares of the company’s stock, valued at approximately $343,628.28. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The disclosure for this sale can be found here. Insiders have sold 17,956 shares of company stock valued at $6,927,011 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $2.55 during midday trading on Thursday, reaching $445.11. The company had a trading volume of 1,225,971 shares, compared to its average volume of 1,514,231. The firm’s fifty day simple moving average is $400.81 and its 200-day simple moving average is $381.34. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $445.79. The company has a market capitalization of $157.88 billion, a P/E ratio of 80.34, a P/E/G ratio of 5.71 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the company posted $1.00 EPS. The business’s revenue was up 11.5% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ISRG shares. Stifel Nicolaus increased their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Piper Sandler increased their price target on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research report on Friday, April 19th. Robert W. Baird cut their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. BTIG Research increased their price target on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Finally, The Goldman Sachs Group initiated coverage on Intuitive Surgical in a research report on Thursday, May 30th. They set a “buy” rating and a $500.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $403.67.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.